Camera, Andrea <br/><br/>
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.  [electronic resource] 

 -  Annals of hematology  Feb 2009 
 - 151-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-008-0571-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Liposomes<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Salvage Therapy<br/>Stem Cell Transplantation<br/>Survival Rate<br/>Time Factors<br/>Vidarabine--administration & dosage